Market cap
$18 Mln
Revenue (TTM)
$57 Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-15 Mln
-
ROE
-0.8 %
-
ROCE
-- %
-
Industry P/E
43.99
-
EV/EBITDA
0.2
-
Debt to Equity
0.6
-
Book Value
$--
-
EPS
$-5.7
-
Face value
--
-
Shares outstanding
7,877,490
10 Years Aggregate
CFO
$-338.49 Mln
EBITDA
$-379.96 Mln
Net Profit
$-411.05 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
ConforMIS Inc (CFMS)
| -31.9 | 0.0 | 105.5 | -66.1 | -50.1 | -39.8 | -- |
|
BSE Sensex*
| -11.2 | -4.2 | -9.2 | -7.4 | 6.8 | 8.7 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
ConforMIS Inc (CFMS)
| -82.5 | 15.3 | -56.0 | 319.0 | -84.8 | -70.6 | -53.2 |
|
S&P Small-Cap 600
| -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 | 24.7 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout ConforMIS Inc (CFMS)
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as... provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts. Read more
-
CEO, Pres & Director
Mr. Mark A. Augusti
-
CEO, Pres & Director
Mr. Mark A. Augusti
-
Headquarters
Billerica, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for ConforMIS Inc (CFMS)
What is the current share price of ConforMIS Inc (CFMS) Today?
The share price of ConforMIS Inc (CFMS) is $2.26 (NASDAQ) as of 14-Sep-2023 09:30 EDT. ConforMIS Inc (CFMS) has given a return of -50.09% in the last 3 years.
What is the current PB & PE ratio of ConforMIS Inc (CFMS)?
Since, TTM earnings of ConforMIS Inc (CFMS) is negative, P/E ratio is not available.
The P/B ratio of ConforMIS Inc (CFMS) is 0.37 times as on 14-Sep-2023, a 87 discount to its peers’ median range of 2.91 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.48
|
0.44
|
|
2021
|
-2.26
|
0.05
|
|
2020
|
-0.09
|
0.19
|
|
2019
|
-0.14
|
0.24
|
|
2018
|
-0.02
|
0.02
|
What is the 52 Week High and Low of ConforMIS Inc (CFMS)?
The 52-week high and low of ConforMIS Inc (CFMS) are Rs -- and Rs -- as of 21-May-2026.
What is the market cap of ConforMIS Inc (CFMS)?
ConforMIS Inc (CFMS) has a market capitalisation of $ 18 Mln as on 14-Sep-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in ConforMIS Inc (CFMS)?
Before investing in ConforMIS Inc (CFMS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.